Company Filing History:
Years Active: 2022-2024
Title: Nina Liu: Innovator in Engineered PD-1 Variants
Introduction
Nina Liu is a prominent inventor based in Larchmont, NY (US). She has made significant contributions to the field of biomedical research, particularly in the development of engineered PD-1 variants. With a total of two patents to her name, her work is paving the way for advancements in immunotherapy.
Latest Patents
Nina Liu's latest patents focus on engineered PD-1 variants. These patents include isolated polypeptides comprising engineered mutant PD-1 polypeptides, as well as fusion polypeptides that incorporate these mutants. The patents also detail bispecific PD-L1 and PD-L2 binding mutant PD-1 polypeptides, along with PD-L2-specific binding mutant PD-1 polypeptides. These innovations hold promise for enhancing therapeutic strategies in cancer treatment.
Career Highlights
Nina Liu is affiliated with the Albert Einstein College of Medicine, where she conducts her research. Her work is characterized by a commitment to advancing the understanding of immune checkpoint inhibitors and their applications in clinical settings.
Collaborations
Some of her notable coworkers include Jonathan R. Lai and Steven Craig Almo. Their collaborative efforts contribute to the innovative research environment at the Albert Einstein College of Medicine.
Conclusion
Nina Liu's contributions to the field of engineered PD-1 variants exemplify her dedication to advancing medical science. Her patents reflect a significant step forward in the development of immunotherapeutic strategies.